- Home
- / Sourcebio International
Sourcebio International
Stock Price
€1.2
2022-12-30
Market Capitalization
€95.1 M
2022-12-30
Revenue
£92.4 M
FY, 2021
Sourcebio International Summary
Company Summary
- Overview
- Sourcebio International is a provider of laboratory services and products. It offers histopathology cancer screening and clinical diagnostic, DNA sequence, precision medicine to pharmaceutical, blood, and tissue serological, and other products.
- Type
- Public
- Status
- Active
- Founded
- 2016
- Cybersecurity rating
Table of Contents
Sourcebio International Financials
Summary Financials
- Revenue (H1, 2022)
- £20.5M
- Gross profit (H1, 2022)
- £9.3M
- Net income (H1, 2022)
- (£2.1M)
- Cash (H1, 2022)
- £15.2M
- EBIT (H1, 2022)
- (£2.3M)
- Enterprise value
- $96.0M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026